⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL271893 | 0.97 | — | — | |
| SCHEMBL609097 | 0.97 | NPC1 (0.44) | — | |
| SCHEMBL607693 | 0.97 | NPC1 (0.44) | — | |
| SCHEMBL128439 | 0.94 | — | — | |
| SCHEMBL10694762 | 0.87 | — | — | |
| SCHEMBL130689 | 0.87 | — | — | |
| SCHEMBL4362759 | 0.85 | NPC1 (0.38) | — | |
| SCHEMBL4356308 | 0.83 | NPC1 (0.32) | — | |
| SCHEMBL6532830 | 0.82 | NPC1 (0.30) | — | |
| SCHEMBL4356940 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 843 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11479550-B2 | EP4 antagonist | ONO PHARMACEUTICAL CO., LTD. (JP) | 2022-10-25 | — | — | US | claimed |
| US-20190322676-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARM INC (US) | 2019-10-24 | — | — | US | claimed |
| WO-2018118838-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2018-06-28 | — | — | WO | claimed |
| CN-102272225-B | Composite conductive polymer composition, method for producing same, solution containing the composition, and use of the composition | SOKEN KAGAKU KK | 2015-07-08 | — | — | CN | claimed |
| CN-102272225-A | Composite conductive polymer composition, method for producing same, solution containing the composition, and use of the composition | — | 2011-12-07 | — | — | CN | claimed |
| US-20240166638-A1 | FUNGICIDAL OXADIAZOLES | FMC CORP (US) | 2024-05-23 | — | — | US | disclosed |
| US-11987658-B2 | Curable resin composition and method of manufacturing article | CANON KABUSHIKI KAISHA (JP) | 2024-05-21 | — | — | US | disclosed |
| CN-118047771-A | Fungicidal oxadiazoles | FMC公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-118047729-A | Fungicidal oxadiazoles | FMC公司 | 2024-05-17 | — | — | CN | disclosed |
| EP-4361150-A2 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | FMC Corporation (US) | 2024-05-01 | — | — | EP | disclosed |
| US-20240122180-A1 | FUNGICIDAL HALOMETHYL KETONES AND HYDRATES AND THEIR MIXTURES | FMC CORPORATION | 2024-04-18 | — | — | US | disclosed |
| EP-4347597-A1 | PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS | Otsuka Pharmaceutical Co., Ltd. (JP) | 2024-04-10 | — | — | EP | disclosed |
| EP-0365678-A1 | 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 1990-05-02 | — | — | EP | disclosed |
| US-4842639-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-06-27 | — | — | US | disclosed |
| US-4775692-A | ANTILIPEMIC, ANTICOAGULANT, HYPOTENSIVE, ANTISECRETORY AND ANTIULCER AGENT | TORAY INDUSTRIES, INC. (JP) | 1988-10-04 | — | — | US | disclosed |
| US-4390548-A | Trans-Δ2 -pge alkylsulphonyl amides | ONO PHARMACEUTICAL CO., LTD. (JP) | 1983-06-28 | — | — | US | disclosed |
| US-4367237-A | THIOPGI-1 DERIVATIVES; OXYTOCICS; PREFERENTIAL | ONO PHARMACEUTICAL CO., LTD. (JP) | 1983-01-04 | — | — | US | disclosed |
| US-4351846-A | 3-Hydroxy and 3-oxo-prostaglandin analogues | ONO PHARMACEUTICAL CO., LTD. (JP) | 1982-09-28 | — | — | US | disclosed |
| US-4284581-A | LITHIUM 1,1'-BINAPHTHYL-2,2'-DIOXYALUMINUM HYDRIDE, REDUCING AGENTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1981-08-18 | — | — | US | disclosed |
| US-4198429-A | BRONCHOSPASMOLYTIC | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-04-15 | — | — | US | disclosed |